RichardAlanFurieMD

PubMed

• What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III Trials.
  Richard Furie, Eric F Morand, Ian N. Bruce, David A. Isenberg, Ronald F van Vollenhoven, Gabriel Abreu, Lilia Pineda, Raj Tummala> ;Arthritis & Rheumatism. 2021 Apr 28
• 1 citations
  Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (ActharGel) for Persist...
  Anca D Askanase, George J Wan, Mary P Panaccio, Enxu Zhao, Julie Zhu, Roman Bilyk, Richard A Furie> ;Rheumatology and therapy. 2021 Mar 1
• Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.
  Loqmane Seridi, Matteo Cesaroni, Ashley Orillion, Jessica Schreiter, Marc Chevrier, Stanley J. Marciniak, Thi-Sau Migone, William Stohl, Walter Winn Chatham, Richard F...> ;Lupus. 2021 Feb 24
• 3 citations
  Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials.
  Raj Tummala, Gabriel Abreu, Lilia Pineda, M Alex Michaels, Rubana N Kalyani, Richard Furie, Eric F Morand> ;Lupus science & medicine. 2021 Feb 1
• 5 citations
  Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study.
  W. Winn Chatham, Richard Furie, Amit Saxena, Philip Z Brohawn, Erik Schwetje, Gabriel Abreu, Raj Tummala> ;Arthritis & Rheumatism. 2021 Mar 24
• 3 citations
  Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis
  Sonali Narain, Nicola Berman, Richard Furie> ;Current Opinion in Rheumatology. 2020 Nov 1
• 2 citations
  Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Control...
  Anca D Askanase, Enxu Zhao, Julie Zhu, Roman Bilyk, Richard A Furie> ;Rheumatology and therapy. 2020 Dec 1
• 101 citations
  Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
  Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi Chiu Mok, Mittermayer Barreto Santiago, Am...> ;The New England Journal of Medicine. 2020 Sep 17
• 2 citations
  Cell-bound complement activation products associate with lupus severity in SLE.
  Cristina Arriens, Roberta Vezza Alexander, Sonali Narain, Amit Saxena, Christopher E Collins, Daniel J. Wallace, Elena Massarotti, John Conklin, Kenneth C. Kalunian, C...> ;Lupus science & medicine. 2020 Apr 1
• Anifrolumab in Systemic Lupus Erythematosus. Reply.
  Morand, E. F., Furie, R. A.> ;The New England journal of medicine. 2020 Apr 23
• 6 citations
  Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations.
  Erik Anderson, Richard Furie> ;Immunotherapy. 2020 Apr 2
• 2 citations
  Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, pl...
  Anca Askanase, Enxu Zhao, Julie Zhu, Erin Connolly-Strong, Richard Furie> ;Lupus science & medicine. 2020 Apr 1
• 223 citations
  Trial of Anifrolumab in Active Systemic Lupus Erythematosus
  Eric F Morand, Richard Furie, Yoshiya Tanaka, Ian N. Bruce, Anca Askanase, Christophe Richez, Sang Cheol Bae, Philip Z Brohawn, Lilia Pineda, Anna Berglind, Raj Tummal...> ;The New England Journal of Medicine. 2020 Jan 16
• 1 citations
  Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.
  Arnon Arazi, Deepak A. Rao, Celine C. Berthier, Anne Davidson, Yanyan Liu, Paul Hoover, Adam Chicoine, Thomas Eisenhaure, A. Helena Jonsson, Shuqiang Li, David J. Lieb...> ;Nature Immunology. 2019 Aug 13
• 43 citations
  Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and revie...
  Nina Kello, Lara El Khoury, Galina Marder, Richard Furie, Ekaterini Zapantis, Diane Horowitz> ;Seminars in Arthritis and Rheumatism. 2019 Aug 1
• 25 citations
  Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus
  Daniel J. Wallace, Ellen M. Ginzler, Joan T. Merrill, Richard Furie, William Stohl, W. Winn Chatham, Arthur Weinstein, James D. McKay, W. Joseph McCune, Michelle Petri...> ;Arthritis & Rheumatism. 2019 Jul 1
• 176 citations
  The immune cell landscape in kidneys of patients with lupus nephritis
  Arnon Arazi, Deepak A. Rao, Celine C. Berthier, Anne Davidson, Yanyan Liu, Paul Hoover, Adam Chicoine, Thomas Eisenhaure, A. Helena Jonsson, Shuqiang Li, David J. Lieb...> ;Nature Immunology. 2019 Jun 17
• 104 citations
  Novel paradigms in systemic lupus erythematosus
  Thomas Dörner, Richard Furie> ;The Lancet. 2019 Jun 8
• 84 citations
  Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
  Richard Furie, Victoria P. Werth, Joseph F. Merola, Lauren Stevenson, Taylor L. Reynolds, Himanshu Naik, Wenting Wang, Romy Christmann, Agnes Gardet, Alex Pellerin, St...> ;Journal of Clinical Investigation. 2019 Mar 1
• 35 citations
  Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults wit...
  Y K Onno Teng, Ian N. Bruce, Betty Diamond, Richard Furie, Ronald F van Vollenhoven, David Gordon, J. Groark, Robert B Henderson, Mary Oldham, Paul P. Tak> ;BMJ Open. 2019 Mar 1
• 3 citations
  Baricitinib for systemic lupus erythematosus – Authors' reply
  Daniel J. Wallace, Richard Furie, Yoshiya Tanaka, Stephanie de Bono, Robert W Hoffman> ;The Lancet. 2019 Feb 2
• 2 citations
  Inflammatory arthritis: a unique presentation of human anaplasmosis.
  Lara El Khoury, Richard Furie> ;Clinical Rheumatology. 2019 Jan 1
• 5 citations
  Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study
  Ronald F van Vollenhoven, William Stohl, Richard Furie, N.L. Fox, J. Groark, Damon Bass, Milena Kurtinecz, Bonnie F Pobiner, William J Eastman, Tania Gonzalez‑Rivera, ...> ;Lupus science & medicine. 2018 Nov 1
• 21 citations
  Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus.
  Joan T. Merrill, Richard Furie, Victoria P. Werth, Munther A. Khamashta, Jorn Drappa, L. Wang, G. Illei, Raj Tummala> ;Lupus science & medicine. 2018 Nov 1
• 22 citations
  Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients
  Weiqing Huang, Tam D. Quach, Cosmin Dascalu, Zheng Liu, Tungming Leung, Miranda Byrne-Steele, Wenjing Pan, Qunying Yang, Jian Han, Martin Lesser, Thomas L. Rothstein, ...> ;JCI insight. 2018 Sep 6
• Join now to see all

Journal Articles

• Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis  
  Richard Furie, Brad H Rovin, The New England Journal of Medicine

Lectures

• 6th Annual Perspectives in Rheumatic Diseases 
  Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
• Advances in B Cell Biology: Rheumatoid Arthritis, Systemic Lupus Erythematosus, & Vasculitis 
  Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Scottsdale, Arizona - 2/18/2012